Acknowledgement
This research was supported by the MRC programs (NRF-2015R1A5A2009656) of the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (NRF-2020R1A2C2011654 and 2019R1A2C2002749).
References
- Rubanyi GM (2000) Angiogenesis in health and disease : basic mechanisms and clinical applications, Dekker, New York
- Tongers J, Roncalli JG and Losordo DW (2008) Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age. Circulation 118, 9-16 https://doi.org/10.1161/CIRCULATIONAHA.108.784371
- Kumar VA, Liu Q, Wickremasinghe NC et al (2016) Treatment of hind limb ischemia using angiogenic peptide nanofibers. Biomaterials 98, 113-119 https://doi.org/10.1016/j.biomaterials.2016.04.032
- Sarkar B, Nguyen PK, Gao W, Dondapati A, Siddiqui Z and Kumar VA (2018) Angiogenic self-assembling peptide scaffolds for functional tissue regeneration. Biomacromolecules 19, 3597-3611 https://doi.org/10.1021/acs.biomac.8b01137
- Licht T, Tsirulnikov L, Reuveni H, Yarnitzky T and Ben-Sasson SA (2003) Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3). Blood 102, 2099-2107 https://doi.org/10.1182/blood-2002-12-3634
- Craik DJ, Fairlie DP, Liras S and Price D (2013) The future of peptide-based drugs. Chem Biol Drug Des 81, 136-147 https://doi.org/10.1111/cbdd.12055
- Frackenpohl J, Arvidsson PI, Schreiber JV and Seebach D (2001) The outstanding biological stability of beta- and gamma-peptides toward proteolytic enzymes: an in vitro investigation with fifteen peptidases. Chembiochem 2, 445-455 https://doi.org/10.1002/1439-7633(20010601)2:6<445::AID-CBIC445>3.0.CO;2-R
- Vlieghe P, Lisowski V, Martinez J and Khrestchatisky M (2010) Synthetic therapeutic peptides: science and market. Drug Discov Today 15, 40-56 https://doi.org/10.1016/j.drudis.2009.10.009
- Bhaskar S and Lim S (2017) Engineering protein nanocages as carriers for biomedical applications. NPG Asia Mater 9, e371 https://doi.org/10.1038/am.2016.128
- Zhang X, Meining W, Fischer M, Bacher A and Ladenstein R (2001) X-ray structure analysis and crystallographic refinement of lumazine synthase from the hyperthermophile Aquifex aeolicus at 1.6 A resolution: determinants of thermostability revealed from structural comparisons. J Mol Biol 306, 1099-1114 https://doi.org/10.1006/jmbi.2000.4435
- Azuma Y, Edwardson TGW and Hilvert D (2018) Tailoring lumazine synthase assemblies for bionanotechnology. Chem Soc Rev 47, 3543-3557 https://doi.org/10.1039/c8cs00154e
- Choi H, Choi B, Kim GJ et al (2018) Fabrication of nanoreaction clusters with dual-functionalized protein cage nanobuilding blocks. Small 14, e1801488
- Kim H, Kang YJ, Min J, Choi H and Kang S (2016) Development of an antibody-binding modular nanoplatform for antibody-guided targeted cell imaging and delivery. RSC Advances 6, 19208-19213 https://doi.org/10.1039/C6RA00233A
- Min J, Kim S, Lee J and Kang S (2014) Lumazine synthase protein cage nanoparticles as modular delivery platforms for targeted drug delivery. RSC Adv 4, 48596-48600 https://doi.org/10.1039/C4RA10187A
- Kang HJ, Kang YJ, Lee YM, Shin HH, Chung SJ and Kang S (2012) Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatform. Biomaterials 33, 5423-5430 https://doi.org/10.1016/j.biomaterials.2012.03.055
- Ra JS, Shin HH, Kang S and Do Y (2014) Lumazine synthase protein cage nanoparticles as antigen delivery nanoplatforms for dendritic cell-based vaccine development. Clin Exp Vaccine Res 3, 227-234 https://doi.org/10.7774/cevr.2014.3.2.227
- Rother M, Nussbaumer MG, Renggli K and Bruns N (2016) Protein cages and synthetic polymers: a fruitful symbiosis for drug delivery applications, bionanotechnology and materials science. Chem Soc Rev 45, 6213-6249 https://doi.org/10.1039/c6cs00177g
- Horiuchi K, Amizuka N, Takeshita S et al (1999) Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 14, 1239-1249 https://doi.org/10.1359/jbmr.1999.14.7.1239
- Takeshita S, Kikuno R, Tezuka K and Amann E (1993) Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J 294 ( Pt 1), 271-278 https://doi.org/10.1042/bj2940271
- Kim BR, Jang IH, Shin SH et al (2014) Therapeutic angiogenesis in a murine model of limb ischemia by recombinant periostin and its fasciclin I domain. Biochim Biophys Acta 1842, 1324-1332 https://doi.org/10.1016/j.bbadis.2014.05.004
- Kim BR, Kwon YW, Park GT et al (2017) Identification of a novel angiogenic peptide from periostin. PLoS One 12, e0187464 https://doi.org/10.1371/journal.pone.0187464
- Zhang Z, Nie F, Chen X et al (2015) Upregulated periostin promotes angiogenesis in keloids through activation of the ERK 1/2 and focal adhesion kinase pathways, as well as the upregulated expression of VEGF and angiopoietin1. Mol Med Rep 11, 857-864 https://doi.org/10.3892/mmr.2014.2827
- Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY and Chang DD (2002) Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(v)/beta(3) and alpha(v)beta(5) integrins and promotes cell motility. Cancer Res 62, 5358-5364
- Gonzalez-Gonzalez L and Alonso J (2018) Periostin: a matricellular protein with multiple functions in cancer development and progression. Front Oncol 8, 225 https://doi.org/10.3389/fonc.2018.00225
- Min J, Kim S, Lee J and Kang S (2014) Lumazine synthase protein cage nanoparticles as modular delivery platforms for targeted drug delivery. Rsc Advances 4, 48596-48600 https://doi.org/10.1039/C4RA10187A
- Schenk S, Schoenhals GJ, de Souza G and Mann M (2008) A high confidence, manually validated human blood plasma protein reference set. BMC Med Genomics 1, 41 https://doi.org/10.1186/1755-8794-1-41
- Strohl WR (2015) Fusion proteins for half-life extension of biologics as a strategy to make biobetters. BioDrugs 29, 215-239 https://doi.org/10.1007/s40259-015-0133-6
- Kim H, Jin S, Choi H et al (2021) Target-switchable Gd(III)-DOTA/protein cage nanoparticle conjugates with multiple targeting affibody molecules as target selective T-1 contrast agents for high-field MRI. J Control Release 335, 269-280 https://doi.org/10.1016/j.jconrel.2021.05.029
- Heo SC, Kwon YW, Jang IH et al (2014) WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells. Stem Cells 32, 779-790 https://doi.org/10.1002/stem.1578
- Kwon YW, Lee SJ, Heo SC et al (2019) Role of CXCR2 in the Ac-PGP-induced mobilization of circulating angiogenic cells and its therapeutic implications. Stem Cells Transl Med 8, 236-246 https://doi.org/10.1002/sctm.18-0035